OTC

Strength

20; 200; 10 mg/10mL; mg/10mL; mg/10mL

NDC

00904653720

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

11/30/2015

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

+1.0%

3M

+5.8%

6M

+8.4%

1Y

+1.6%

3Y

+26.6%

5Y

+24.0%

All

+20.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.